NINGBO INNO PHARMCHEM CO.,LTD. is a leading supplier of high-purity chemicals for advanced scientific research. Cyclopentenyl Cytosine (CAS 90597-22-1) is a notable compound within its catalog, primarily recognized for its potent activity as a ribonucleotide reductase inhibitor. This characteristic is central to its cytotoxic effects and its utility in cancer research.

Ribonucleotide reductase (RR) is a vital enzyme in cellular metabolism, responsible for catalyzing the synthesis of deoxyribonucleotides from ribonucleotides. These deoxyribonucleotides are the essential precursors for DNA synthesis and repair. Consequently, inhibiting RR activity leads to a depletion of the cellular pool of deoxyribonucleotides, which in turn arrests DNA replication and cell proliferation. This mechanism is a common target for many anticancer drugs.

Cyclopentenyl Cytosine functions as a direct inhibitor of ribonucleotide reductase. By binding to and deactivating this enzyme, it effectively blocks the production of deoxyribonucleotides. This disruption is the primary driver behind the compound's significant cyclopentenyl cytosine cytotoxic effects. The cyclopentenyl cytosine mechanism of action is thus directly linked to the interruption of DNA synthesis, making it a potent agent against rapidly dividing cells, such as cancer cells.

The ability of Cyclopentenyl Cytosine to act as a ribonucleotide reductase inhibitor is a critical aspect of its cyclopentenyl cytosine biological activity. This inhibitory action has been observed to be effective against various cancer cell lines, highlighting its potential for therapeutic applications. Researchers utilize Cyclopentenyl Cytosine in studies to understand the consequences of RR inhibition and to develop new drug candidates that exploit this pathway. The cyclopentenyl cytosine cancer cell lines research benefits greatly from the specific action of this compound.

Beyond its direct inhibitory action, Cyclopentenyl Cytosine also serves as a valuable pharmaceutical intermediate. Its chemical structure and properties allow for further modification and incorporation into more complex drug molecules. NINGBO INNO PHARMCHEM CO.,LTD. ensures the availability of this compound at high purity, supporting the rigorous demands of pharmaceutical development. The compound’s role extends to understanding cellular stress responses and metabolic pathways in cancer.

In conclusion, Cyclopentenyl Cytosine (CAS 90597-22-1) plays a critical role in cancer research due to its potent inhibition of ribonucleotide reductase. This action directly impairs DNA synthesis, leading to significant cytotoxic effects on cancer cells. NINGBO INNO PHARMCHEM CO.,LTD. is proud to supply this essential chemical, contributing to the advancement of cancer therapies and drug development.